Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Spotlighting the hypoxia-centrosome amplification axis.

Mittal K, Aneja R.

Med Res Rev. 2020 Feb 10. doi: 10.1002/med.21663. [Epub ahead of print]


A quantitative centrosomal amplification score predicts local recurrence in ductal carcinoma in situ.

Mittal K, Toss MS, Wei G, Kaur J, Choi DH, Melton BD, Osan RM, Milligy IM, Green AR, Janssen EAM, Søiland H, Gogineni K, Manne U, Rida P, Rakha EA, Aneja R.

Clin Cancer Res. 2020 Jan 14. pii: clincanres.1272.2019. doi: 10.1158/1078-0432.CCR-19-1272. [Epub ahead of print]


Panoptic View of Prognostic Models for Personalized Breast Cancer Management.

Saini G, Mittal K, Rida P, Janssen EAM, Gogineni K, Aneja R.

Cancers (Basel). 2019 Sep 7;11(9). pii: E1325. doi: 10.3390/cancers11091325. Review.


Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.

Toss M, Miligy I, Gorringe K, Mittal K, Aneja R, Ellis I, Green A, Rakha E.

J Clin Pathol. 2020 Feb;73(2):76-82. doi: 10.1136/jclinpath-2019-205939. Epub 2019 Aug 23.


Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study.

Bhattarai S, Klimov S, Mittal K, Krishnamurti U, Li XB, Oprea-Ilies G, Wetherilt CS, Riaz A, Aleskandarany MA, Green AR, Ellis IO, Cantuaria G, Gupta M, Manne U, Agboola J, Baskovich B, Janssen EAM, Callagy G, Walsh EM, Mehta A, Dogra A, Shet T, Gajaria P, Traina T, Nggada HA, Omonisi A, Ahmed SA, Rakha EA, Rida P, Aneja R.

Cancers (Basel). 2019 Jul 17;11(7). pii: E995. doi: 10.3390/cancers11070995.


Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ.

Toss MS, Miligy IM, Gorringe KL, Aleskandarany MA, Alkawaz A, Mittal K, Aneja R, Ellis IO, Green AR, Rakha EA.

Mod Pathol. 2019 Oct;32(10):1460-1472. doi: 10.1038/s41379-019-0286-9. Epub 2019 Jun 7.


Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study.

Toss MS, Miligy IM, Gorringe KL, AlKawaz A, Mittal K, Aneja R, Ellis IO, Green AR, Roxanis I, Rakha EA.

Mod Pathol. 2019 Oct;32(10):1473-1485. doi: 10.1038/s41379-019-0296-7. Epub 2019 Jun 7.


The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ.

Toss MS, Miligy IM, Haj-Ahmad R, Gorringe KL, AlKawaz A, Mittal K, Ellis IO, Green AR, Rakha EA.

Histopathology. 2019 Jun;74(7):1025-1035. doi: 10.1111/his.13835. Epub 2019 Apr 14.


Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer.

Mittal K, Donthamsetty S, Kaur R, Yang C, Gupta MV, Reid MD, Choi DH, Rida PCG, Aneja R.

Br J Cancer. 2017 Apr 25;116(9):1186-1194. doi: 10.1038/bjc.2017.78. Epub 2017 Mar 23.


Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.

Mittal K, Choi DH, Ogden A, Donthamsetty S, Melton BD, Gupta MV, Pannu V, Cantuaria G, Varambally S, Reid MD, Jonsdottir K, Janssen EA, Aleskandarany MA, Ellis IO, Rakha EA, Rida PC, Aneja R.

Sci Rep. 2017 Mar 8;7:43984. doi: 10.1038/srep43984.


Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer.

Ogden A, Garlapati C, Li XB, Turaga RC, Oprea-Ilies G, Wright N, Bhattarai S, Mittal K, Wetherilt CS, Krishnamurti U, Reid MD, Jones M, Gupta M, Osan R, Pattni S, Riaz A, Klimov S, Rao A, Cantuaria G, Rida PC, Aneja R.

Sci Rep. 2017 Feb 20;7:42289. doi: 10.1038/srep42289.


A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.

Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PCG, Aneja R.

J Ovarian Res. 2016 Mar 18;9:17. doi: 10.1186/s13048-016-0224-0.


Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.

Mittal K, Ogden A, Reid MD, Rida PC, Varambally S, Aneja R.

Cell Cycle. 2015;14(17):2798-809. doi: 10.1080/15384101.2015.1068478.


Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.

Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R.

Oncotarget. 2015 Apr 30;6(12):10487-97.

Supplemental Content

Loading ...
Support Center